Association Between Lipoprotein(a) and Dilatation of Different Aortic Segments in Hypertensive Patients

Lin Wang1, Chaoqun Ma2, Xiaowei Liu1

  • 1Department of Cardiology, Zhejiang Hospital, Hangzhou, Zhejiang, China.

PubMed

Insights

Elevated lipoprotein(a) levels are linked to aortic root dilatation in hypertensive patients. This study identifies Lp(a) as an independent predictor of aortic root dimensions, particularly in individuals with hypertension.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Hypertension Research

Background:

  • Limited research exists on the association between lipoprotein(a) [Lp(a)] and aortic root dimensions (ARDMs).
  • Hypertension is a significant risk factor for cardiovascular diseases, potentially influencing ARDMs.

Purpose of the Study:

  • To investigate the relationship between Lp(a) levels and ARDMs in hypertensive patients.
  • To determine if Lp(a) is an independent predictor of aortic root dilatation.

Main Methods:

  • Echocardiography was used to measure ARDMs (aortic valve annulus, sinuses of Valsalva, sinotubular junction, ascending aorta) in 513 hospitalized patients.
  • Lp(a) levels and other laboratory parameters were analyzed.
  • Statistical analysis, including regression and restricted cubic spline analysis, was performed.

Main Results:

  • Lp(a) showed a positive and independent association with the diameter of the sinuses of Valsalva (SV) and sinotubular junction (STJ) in hypertensive patients.
  • Elevated Lp(a) levels were independently associated with SV dilatation (SVD) and ascending aorta dilatation (AAD) in hypertensive individuals.
  • Subgroup analysis revealed significant associations between Lp(a) and SVD across all groups, and with AAD in males and younger patients (≤65 years).

Conclusions:

  • Elevated Lp(a) concentrations are intricately linked to ARDMs at the SV and STJ in hypertensive patients.
  • Lp(a) serves as a standalone indicator for SVD and AAD in this population.
  • Further research may explore Lp(a) as a therapeutic target for preventing aortic root dilatation in hypertensive individuals.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
650